T 0561/22 of 07.01.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T056122.20250107
- Date of decision
- 7 January 2025
- Case number
- T 0561/22
- Petition for review of
- -
- Application number
- 13809694.6
- IPC class
- A61K 31/7088C12N 15/113
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Modulation of UBE3A-ATS expression
- Applicant name
- Ionis Pharmaceuticals, Inc.
Baylor College Of Medicine - Opponent name
- F.Hoffmann-La Roche AG
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.